{{Rsnum
|rsid=6691847
|Chromosome=1
|position=29792805
|Orientation=plus
|GMAF=0.1818
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.6 | 20.4 | 0.0
| HCB | 60.6 | 35.0 | 4.4
| JPT | 63.7 | 33.6 | 2.7
| YRI | 54.4 | 39.5 | 6.1
| ASW | 63.2 | 29.8 | 7.0
| CHB | 60.6 | 35.0 | 4.4
| CHD | 54.1 | 38.5 | 7.3
| GIH | 73.3 | 26.7 | 0.0
| LWK | 58.2 | 34.5 | 7.3
| MEX | 69.0 | 31.0 | 0.0
| MKK | 67.9 | 27.6 | 4.5
| TSI | 76.5 | 21.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535911
  |Trait=Non-alcoholic fatty liver disease
  |Title=Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
  |RiskAllele=C
  |Pval=7E-6
  |OR=1.32
  |ORtxt=[0.98-1.77]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}